Stockscreener 앱 받기
5.65
2.92%
-0.17
전일 마감가:
$5.82
열려 있는:
$5.8
하루 거래량:
314.36K
Relative Volume:
1.66
시가총액:
$474.01M
수익:
$81.18M
순이익/손실:
$-80.94M
주가수익비율:
-4.7845
EPS:
-1.1809
순현금흐름:
$-55.15M
1주 성능:
+5.61%
1개월 성능:
+8.24%
6개월 성능:
+6.81%
1년 성능:
+50.67%
1일 변동 폭
$5.50
$5.81
1주일 범위
$4.95
$5.835
52주 변동 폭
$2.92
$6.30
Sophia Genetics Sa Stock (SOPH) Company Profile
Compare SOPH vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.65 | 474.01M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
190.12 | 30.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
71.43 | 14.02B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.23 | 10.46B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.40 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
88.80 | 6.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Craig Hallum | Buy |
| 2024-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-03 | 개시 | BTIG Research | Buy |
| 2022-11-23 | 개시 | Credit Suisse | Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-17 | 개시 | Cowen | Outperform |
| 2021-08-17 | 개시 | Credit Suisse | Outperform |
| 2021-08-17 | 개시 | JP Morgan | Overweight |
| 2021-08-17 | 개시 | Morgan Stanley | Overweight |
모두보기
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $93,376.80 in Stock - MarketBeat
Tax-driven SOPHiA GENETICS (NASDAQ: SOPH) share sale under 10b5-1 plan - Stock Titan
Form 144 SOPHIA GENETICS SA For: 7 July By Investing.com - Investing.com South Africa
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $21,417.05 in Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) CEO Ross Muken Sells 9,838 Shares - MarketBeat
Jurgi Camblong Sells 22,486 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPH (NASDAQ) director sells 65,269 shares under 10b5-1 plan - Stock Titan
CFO of SOPHiA GENETICS (NASDAQ: SOPH) sells 1,592 shares for taxes - Stock Titan
SOPHiA GENETICS (SOPH) CPO sells shares to cover RSU tax withholding - Stock Titan
SOPHiA GENETICS (SOPH) CTO’s 5,285-share sale covers RSU tax via 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CSO Xu sheds 7,393 shares in tax-related Rule 10b5-1 sale - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) exec sells 216 shares to cover taxes - Stock Titan
SOPHiA GENETICS (SOPH) chair sells 22,486 shares under 10b5-1 tax plan - Stock Titan
SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares - AOL.com
Form 144 SOPHIA GENETICS SA For: 6 July By Investing.com - Investing.com Nigeria
SOPH (NASDAQ) insider Philippe Menu reports multiple 10b5-1 sales - Stock Titan
SOPH (NASDAQ) holder ZHENYU XU lists multiple 10b5-1 sales in Form 144 - Stock Titan
SOPH (NASDAQ) insider 10b5-1 sells 4,590 shares; 1,592 RSUs planned - Stock Titan
SOPH (NASDAQ) affiliate files Form 144 to sell 9,838 RSUs; 10b5-1 trades listed - Stock Titan
Manuela Valente sells SOPH shares under 10b5-1 plan (SOPH) - Stock Titan
SOPHiA GENETICS (SOPH) Declines 3% as Stock Approaches Key Support LevelMcClellan Summation - dars.gov.et
SOPHiA GENETICS (SOPH) chair sells 83,679 shares and exercises options - Stock Titan
SOPH (NASDAQ) affiliate sells via 10b5-1; 50,069-share trade listed - Stock Titan
Form 144 SOPHIA GENETICS SA For: 29 June - Investing.com UK
Form 144 SOPHIA GENETICS SA For: 29 June By Investing.com - Investing.com South Africa
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $290,400.20 in Stock - MarketBeat
JURGI CAMBLONG (SOPH) lists 10b5-1 sales, largest 50,069 shares on 06/26/2026 - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) CEO sells 51,442 shares under Rule 10b5-1 plan - Stock Titan
Enterprise value to EBIT forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBITDA forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBITDA forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Price to earnings forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Price to earnings forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Price to book forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBIT forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Enterprise value to revenue forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA - GuruFocus
SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares of Stock - MarketBeat
Jurgi Camblong sells shares under 10b5-1 plan — SOPH (NASDAQ: SOPH) - Stock Titan
SOPHiA GENETICS (SOPH) CMO sells 5,000 shares in Rule 10b5-1 trade - Stock Titan
SOPHiA GENETICS (SOPH) CTO sells shares to cover tax withholding - Stock Titan
Form 144 SOPHIA GENETICS SA For: 25 June - Investing.com UK
SOPHiA GENETICS SA Actuals & Estimates (NASDAQ:SOPH) - TradingView
Form 144 SOPHIA GENETICS SA For: 25 June By Investing.com - Investing.com Nigeria
SOPH (NASDAQ: SOPH) insider sells tens of thousands of shares under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CFO’s small 774-share sale covers RSU tax bill - Stock Titan
SOPHiA GENETICS (SOPH) president sells 422 shares to cover RSU taxes - Stock Titan
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On? - Insider Monkey
Total debt per share of SOPHiA GENETICS SA – DUS:90B - TradingView
Cash flow from operating activities of SOPHiA GENETICS SA – DUS:90B - TradingView
SOPHiA GENETICS SA Cash Flow – DUS:90B - TradingView
Sophia Genetics Sa (SOPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.61%
자본화:
|
볼륨(24시간):